Ambrosia Plasma relaunches - announces improvement in key ageing biomarkers
The Club interviews Jesse Karmazin, CEO, to find out more about the trial, the FDA warning, and the relaunch
Join the club for FREE to access the whole archive and other member benefits.
Offers young blood plasma transfers after running a trial in 2016-18
We offer infusions of young blood from donors ages 16 to 25. This is an outpatient procedure. You must be at least 30 years old to receive this treatment.
Our blood is obtained from licensed blood banks within the United States. We do not work directly with donors.
The treatments we offer, infusions of blood products, are approved in the United States.
Visit website: https://www.ambrosiaplasma.com/
Ambrosia-Plasma-223771048398667
Details last updated 04-Feb-2019
The Club interviews Jesse Karmazin, CEO, to find out more about the trial, the FDA warning, and the relaunch
Summary of “Turning back time with emerging rejuvenation Strategies” published in Nature Cell Biology
OneZero - 08-Nov-2019
No further clinical trials planned, but some interesting results from initial trial
Read more...CNN - 19-Feb-2019
Only 2 months after starting. Calling it a medical treatment may be contravened FDA guidance.
Read more...Wired - 09-May-2018
GDF11 is a protein in the blood, which can stimulate cell growth and repair
Read more...STAT - 02-Mar-2018
Bill Faloon inviting people to join a pay-to-participate clinical trial. Will test transfusions ...
Read more...National Post - 03-Nov-2017
Billionaires are now pouring millions into longevity research. Upgrading the human immune system...
Read more...New Scientist - 31-May-2017
Update on Ambrosia trial that gives blood plasma from under 25s to older people. Recipients have...
Read more...Dan’s Plan - 20-Jan-2017
Interview with Drs. Michael and Irina Conboy of the Department of Bioengineering at UC Berkeley. ...
Read more...Science - 01-Aug-2016
Ambrosia (https://www.ambrosiaplasma.com/) young plasma trial is open to anyone 35 and older. Pa...
Read more...